Samantha Pearce Jazz Pharmaceuticals PLC (JAZZ) insider trading activity

Samantha Pearce is EVP, Chief Commercial Officer of Jazz Pharmaceuticals plc. Currently has a direct ownership of 24,078 shares of JAZZ, which is worth approximately $3 Million. The most recent transaction as insider was on Aug 02, 2024, when has been sold 6,996 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.1K

0% 3M change

82.98% 12M change

Total Value Held $3 Million

Samantha Pearce Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 02 2024	BUY Grant, award, or other acquisition	-	6,996 Added 22.51%	24,078 Ordinary Shares
Mar 05 2024	SELL Payment of exercise price or tax liability	$290,769 $117.53 p/Share	2,474 Reduced 12.76%	16,922 Ordinary Shares
Mar 01 2024	BUY Grant, award, or other acquisition	-	5,065 Added 20.71%	19,396 Ordinary Shares
Jan 17 2024	SELL Payment of exercise price or tax liability	$123,656 $119.13 p/Share	1,038 Reduced 6.75%	14,331 Ordinary Shares
Jan 17 2024	BUY Grant, award, or other acquisition	-	2,210 Added 12.57%	15,369 Ordinary Shares
Mar 05 2023	SELL Payment of exercise price or tax liability	$288,415 $142.78 p/Share	2,020 Reduced 13.31%	13,159 Ordinary Shares
Mar 03 2023	BUY Grant, award, or other acquisition	-	3,870 Added 20.32%	15,179 Ordinary Shares
Feb 02 2023	SELL Open market or private sale	$83,505 $157.26 p/Share	531 Reduced 4.48%	11,309 Ordinary Shares
Feb 02 2023	BUY Exercise of conversion of derivative security	$58,117 $109.45 p/Share	531 Added 4.29%	11,840 Ordinary Shares
Jan 03 2023	SELL Open market or private sale	$84,742 $159.59 p/Share	531 Reduced 4.48%	11,309 Ordinary Shares
Jan 03 2023	BUY Exercise of conversion of derivative security	$58,117 $109.45 p/Share	531 Added 4.29%	11,840 Ordinary Shares
Dec 13 2022	SELL Open market or private sale	$82,543 $155.45 p/Share	531 Reduced 4.48%	11,309 Ordinary Shares
Dec 13 2022	BUY Exercise of conversion of derivative security	$58,117 $109.45 p/Share	531 Added 4.29%	11,840 Ordinary Shares
Nov 10 2022	SELL Open market or private sale	$164,765 $155.0 p/Share	1,063 Reduced 8.59%	11,309 Ordinary Shares
Nov 10 2022	BUY Exercise of conversion of derivative security	$116,345 $109.45 p/Share	1,063 Added 8.24%	11,840 Ordinary Shares
Sep 02 2022	SELL Open market or private sale	$83,356 $156.98 p/Share	531 Reduced 4.48%	11,309 Ordinary Shares
Sep 02 2022	BUY Exercise of conversion of derivative security	$58,118 $109.45 p/Share	531 Added 4.29%	11,840 Ordinary Shares
Aug 04 2022	SELL Open market or private sale	$82,305 $155.0 p/Share	531 Reduced 4.48%	11,309 Ordinary Shares
Aug 04 2022	BUY Exercise of conversion of derivative security	$58,118 $109.45 p/Share	531 Added 4.29%	11,840 Ordinary Shares
Jul 12 2022	SELL Open market or private sale	$82,460 $155.0 p/Share	532 Reduced 4.49%	11,309 Ordinary Shares
Jul 12 2022	BUY Exercise of conversion of derivative security	$58,227 $109.45 p/Share	532 Added 4.3%	11,841 Ordinary Shares
Jun 27 2022	SELL Open market or private sale	$1,318,740 $155.0 p/Share	8,508 Reduced 42.93%	11,309 Ordinary Shares
Jun 27 2022	BUY Exercise of conversion of derivative security	$931,201 $109.45 p/Share	8,508 Added 30.04%	19,817 Ordinary Shares
Jun 08 2022	SELL Open market or private sale	$1,315,485 $155.0 p/Share	8,487 Reduced 42.87%	11,309 Ordinary Shares
Jun 08 2022	BUY Exercise of conversion of derivative security	$638,641 $109.45 p/Share	5,835 Added 22.77%	19,796 Ordinary Shares

Samantha Pearce

EVP, Chief Commercial Officer

Dublin 4, L2

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAZZ shares.

Notify only if

Value

Insider Trading

Get notified when an Jazz Pharmaceuticals PLC insider buys or sells JAZZ shares.

Notify only if

Operation

Value

Type

News

Receive news related to Jazz Pharmaceuticals plc

Track Activities on JAZZ

Account